In conclusion, our study demonstrates that the endothelial expression of Ang2 and podoplanin can differentiate patients likely to exhibit more aggressive and advanced HCC, particularly in females where normal hormonal protection diminishes with age. This evidence concerns the gene ANGPT2 and hepatocellular carcinoma.